Clinical Trial Update: BIOFLOW-VIII All-comers Orsiro Mission Safety and Performance Registry

View source ↗

Summary

Clinical trial update for the BIOFLOW-VIII registry evaluating Orsiro sirolimus-eluting stents in all-comers with coronary artery disease and myocardial ischemi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Myocardial Ischemia

Drugs mentioned

• Orsiro (Sirolimus-eluting stent)

Snippet

Sponsor: Biotronik AG | Conditions: Coronary Artery Disease, Myocardial Ischemia | Status: ACTIVE_NOT_RECRUITING